172 related articles for article (PubMed ID: 20859151)
21. Safety of vaginal estrogens: a systematic review.
Crandall CJ; Diamant A; Santoro N
Menopause; 2020 Mar; 27(3):339-360. PubMed ID: 31913230
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.
Bachmann G; Bouchard C; Hoppe D; Ranganath R; Altomare C; Vieweg A; Graepel J; Helzner E
Menopause; 2009; 16(4):719-27. PubMed ID: 19436223
[TBL] [Abstract][Full Text] [Related]
23. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
Pickar JH; Amadio JM; Hill JM; Bernick BA; Mirkin S
Menopause; 2016 May; 23(5):506-10. PubMed ID: 26836245
[TBL] [Abstract][Full Text] [Related]
25. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
Steiner AZ; Xiang M; Mack WJ; Shoupe D; Felix JC; Lobo RA; Hodis HN
Obstet Gynecol; 2007 Mar; 109(3):581-7. PubMed ID: 17329508
[TBL] [Abstract][Full Text] [Related]
26. Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets.
Derzko CM; Röhrich S; Panay N
Menopause; 2020 Oct; 28(2):113-118. PubMed ID: 33038141
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
Shulman LP; Yankov V; Uhl K
Menopause; 2002; 9(3):195-207. PubMed ID: 11973443
[TBL] [Abstract][Full Text] [Related]
28. Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review.
Constantine GD; Graham S; Lapane K; Ohleth K; Bernick B; Liu J; Mirkin S
Menopause; 2019 Jul; 26(7):800-807. PubMed ID: 30889085
[TBL] [Abstract][Full Text] [Related]
29. Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
Samsioe G; Boschitsch E; Concin H; De Geyter C; Ehrenborg A; Heikkinen J; Hobson R; Arguinzoniz M; Ibarra de Palacios P; Scheurer C; Schmidt G;
Climacteric; 2006 Oct; 9(5):368-79. PubMed ID: 17080587
[TBL] [Abstract][Full Text] [Related]
30. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
Portman DJ; Symons JP; Wilborn W; Kempfert NJ
Am J Obstet Gynecol; 2003 Feb; 188(2):334-42. PubMed ID: 12592236
[TBL] [Abstract][Full Text] [Related]
32. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P
Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634
[TBL] [Abstract][Full Text] [Related]
33. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.
Pinkerton JV; Shifren JL; La Valleur J; Rosen A; Roesinger M; Siddhanti S
Menopause; 2003; 10(1):45-52. PubMed ID: 12544676
[TBL] [Abstract][Full Text] [Related]
34. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
[TBL] [Abstract][Full Text] [Related]
35. Effect of estradiol vaginal gel on vaginal atrophy in postmenopausal women: A randomized double-blind controlled trial.
Tanmahasamut P; Jirasawas T; Laiwejpithaya S; Areeswate C; Dangrat C; Silprasit K
J Obstet Gynaecol Res; 2020 Aug; 46(8):1425-1435. PubMed ID: 32715556
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
[TBL] [Abstract][Full Text] [Related]
37. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.
Quaas AM; Kono N; Mack WJ; Hodis HN; Felix JC; Paulson RJ; Shoupe D
Menopause; 2013 Aug; 20(8):840-4. PubMed ID: 23422867
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
40. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
